The Motley Fool. DATE Tuesday, July 22, 2025 at 4:30 p.m. ET Read More: Earn up to $845 cash back this year just by changing how you pay at Costco! Learn more here. CALL PARTICIPANTS Chief Executive ...

When EID yields positive resection margins, or reveals high-risk features for ... potential of EID to shift the treatment paradigm for low to intermediate-risk T1 rectal cancer and selected T2 cases, ...

Background Endoscopic intermuscular dissection (EID) is a promising new technique for managing rectal deep submucosal invasive cancer (D-SMIC), but long-term outcome data are currently lacking.

Even though rectal bleeding is alarming, doctors say patients are ashamed to mention it, delaying colon cancer diagnosis and treatment.

A new trial of patients with advanced rectal cancer has found that the addition of immunotherapy treatment alongside extended radiotherapy led to better rates of remission.

Real-world data support clinical trial results showing less gastrointestinal toxicity with use of a rectal spacer during prostate cancer radiation therapy.

A new study found that the immunotherapy treatment worked against some types of cancers, allowing patients to avoid surgery and other types of more invasive treatment to cure their disease.

Abstract Breast metastasis from gastrointestinal cancers is uncommon, accounting for 0.5% to 2% of breast cancer cases. The clinical and radiological manifestations may resemble those of primary ...

A New Paradigm in Rectal Cancer Treatment Together, these five studies demonstrate the transformative potential of radiotherapy as a curative and organ-preserving treatment.

“With FDA’s clearance of the da Vinci SP system for transanal local resection, surgeons have a new option in colorectal surgery to positively impact patient outcomes,” said Intuitive ...